Information Provided By:
Fly News Breaks for October 25, 2016
HCA
Oct 25, 2016 | 09:17 EDT
Wolfe Research analyst Justin Lake initiated HCA Holdings with an Outperform and a $95 price target. The analyst said HCA's combination of faster growing markets, significant investment, and strong free cash flow make this the most attractive stock under coverage for the short and intermediate term.
News For HCA From the Last 2 Days
HCA
Apr 26, 2024 | 08:53 EDT
Check out this morning's top movers from around Wall Street, compiled by The Fly.  HIGHER - U... To see the rest of the story go to thefly.com. See Story Here
HCA
Apr 25, 2024 | 13:10 EDT
Notable companies reporting before tomorrow's open, with earnings consensus, include Exxon Mobil (XOM), consensus $2.20... Chevron (CVX), consensus $2.87... AbbVie (ABBV), consensus $2.23... HCA Healthcare (HCA), consensus $5.01... Colgate-Palmolive (CL), consensus 81c... Charter (CHTR), consensus $7.92... AutoNation (AN), consensus $4.27.
HCA
Apr 24, 2024 | 08:40 EDT
Catheter Precision (VTAK) has received its first purchase order for LockeT from an HCA Healthcare (HCA) facility.
HCA
Apr 24, 2024 | 07:14 EDT
Augmedix (AUGX) announced the general availability of Augmedix Go for emergency departments, marking the launch of the industry's first fully-automated, generative AI powered medical documentation product for EDs across the country. The launch incorporates learnings from a pilot program with HCA Healthcare (HCA), one of the nation's leading healthcare providers. As part of the pilot, ED physicians in four HCA Healthcare hospitals utilized Augmedix Go to automate medical documentation, with the product instantaneously drafting their medical notes from patient visits. "The launch of Augmedix Go in the ED represents our unwavering commitment to develop solutions for health systems that improve their workflows. Our agility and flexible architecture, exhibited by our broad product suite and open network platform, help us address the complex and varying needs of clinicians and providers," said Manny Krakaris, CEO of Augmedix. "We have built a sophisticated platform designed to enable clinicians to be present with their patients while trusting that Augmedix technology is doing administrative work unobtrusively in the background."